Healthcare intellectual property commercialisation group Netscientific has today highlighted a positive report displaying the potential of Vortex Technology in cancer treatment. Research into the technology, developed by Netscientific's portfolio company Vortex Biosciences, has yielded positive results according to the report published by Nature Scientific Reports. Francois Martelet, chairman of Vortex Biosciences, said: "This report demonstrates the potential clinical utility of circulating ...Den vollständigen Artikel lesen ...